Physician

Abdullah Haroon Lakhani, MD

According to 2025 Medicare claims, Abdullah Lakhani, MD (NPI: 1497145916) practices neuropsychiatry in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is COMMUNITY HEALTH PARTNERS (NPI: 1952912420; TIN: 85-2103299) and primary practice location at 93720-2950.

Lakhani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 253 traditional Medicare patients, billed 423 HCPCS/CPT codes, and received $41,256 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,370 prescription claims across 254 beneficiaries totaling $278,446 in drug costs, led by Qulipta (Atogepant). Open Payments data shows 7 records totaling $308. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$23K$46K2022 Medicare payment: $46,304 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $43,125 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $41,256 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022289410$46,304
2023306524$43,125
2024253423$41,256

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$139K$278K2022 Drug cost: $56,417 (USD; Tot_Drug_Cst)2023 Drug cost: $254,911 (USD; Tot_Drug_Cst)2024 Drug cost: $278,446 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022165619$56,417
20232431,015$254,911
20242541,370$278,446

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more2020$160
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2427$125
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more9595$123
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more140195$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5055$55

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
QuliptaAtogepant23750$26,614
FycompaPerampanel19532$24,740
Emgality PenGalcanezumab-Gnlm24716$18,675
RufinamideRufinamide12360$12,934
LevetiracetamLevetiracetam1126,973$4,988

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$308ACADIA Pharmaceuticals Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdullah Haroon Lakhani, MD?

Tedicare shows public-source Medicare data for Abdullah Haroon Lakhani, MD (NPI 1497145916), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdullah Haroon Lakhani, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdullah Haroon Lakhani, MD?

Abdullah Haroon Lakhani, MD is linked to COMMUNITY HEALTH PARTNERS (billing NPI 1952912420) in the available physician profile data.

Does Abdullah Haroon Lakhani, MD have Open Payments data?

Abdullah Haroon Lakhani, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.